Affordable Access

Publisher Website

A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a Killer

Authors
Journal
Cancer Cell
1535-6108
Publisher
Elsevier
Publication Date
Volume
14
Issue
4
Identifiers
DOI: 10.1016/j.ccr.2008.09.002
Keywords
  • Humdisease
  • Proteins
  • Cellbio
Disciplines
  • Biology
  • Medicine

Abstract

Summary Bcl-2 can be converted into a proapoptotic molecule by nuclear receptor Nur77. However, the development of Bcl-2 converters as anticancer therapeutics has not been explored. Here we report the identification of a Nur77-derived Bcl-2-converting peptide with 9 amino acids (NuBCP-9) and its enantiomer, which induce apoptosis of cancer cells in vitro and in animals. The apoptotic effect of NuBCPs and their activation of Bax are not inhibited but rather potentiated by Bcl-2. NuBCP-9 and its enantiomer bind to the Bcl-2 loop, which shares the characteristics of structurally adaptable regions with many cancer-associated and signaling proteins. NuBCP-9s act as molecular switches to dislodge the Bcl-2 BH4 domain, exposing its BH3 domain, which in turn blocks the activity of antiapoptotic Bcl-X L.

There are no comments yet on this publication. Be the first to share your thoughts.